DAX23.740 ±0,0%ESt505.504 +0,1%Top 10 Crypto15,47 +1,0%Dow46.247 +0,7%Nas22.484 +0,4%Bitcoin95.649 -0,2%Euro1,1715 +0,2%Öl69,04 -1,0%Gold3.828 +1,7%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
Rheinmetall 703000 DroneShield A2DMAA RENK RENK73 Lufthansa 823212 NVIDIA 918422 Novo Nordisk A3EU6F HENSOLDT HAG000 Tesla A1CX3T Siemens Energy ENER6Y BYD A0M4W9 Deutsche Telekom 555750 Mercedes-Benz Group (ex Daimler) 710000 Allianz 840400 BASF BASF11 SAP 716460
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
DAX stabil -- Lufthansa: Restrukturierung und drohende Streiks -- Canopy Growth, Alibaba, D-Wave & Co., Novo Nordisk, Occidental, DroneShield, Rüstungsaktien, BYD, Goldpreis, Autoaktien im Fokus
Top News
Investment-Tipp: So bewertet Deutsche Bank AG die BASF-Aktie Investment-Tipp: So bewertet Deutsche Bank AG die BASF-Aktie
Auf dem Verkaufszettel: Diese Aktien empfehlen Experten zu verkaufen Auf dem Verkaufszettel: Diese Aktien empfehlen Experten zu verkaufen
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil

PTC Therapeutics Aktie

Kaufen
Verkaufen
Aktien-Sparplan anlegen
50,00 EUR +0,80 EUR +1,63 %
FSE
59,50 USD +1,65 USD +2,85 %
vorbörslich
BTT
PTC Therapeutics jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 11/2024)
Smartphone

Marktkap.4,00 Mrd. EUR

Div. Rendite0,00%
WKN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

WKNA1W0MW

ISIN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

ISINUS69366J2006

Symbol wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

SymbolPTCT

PTC Therapeutics Aktien News

DatumMeistgelesen
BenzingaPTC Therapeutics Could Challenge BioMarin For Metabolic Disorder Treatment
MotleyFoolHere's Why Shares in PTC Therapeutics Soared This Week
BenzingaPTC Therapeutics Stock Is Stuck In A Multi-Year Slump
Wer­bungPTC Therapeutics-Aktie für 0 Euro (zzgl. Spreads) handeln bei finanzen.net zero
PR NewswirePTC Therapeutics to Participate at Upcoming Investor Conferences
BenzingaPTC Therapeutics Faces FDA Rejection On Rare Disease Treatment Over Efficacy Concerns
PR NewswirePTC Therapeutics Receives Complete Response Letter for Vatiquinone NDA
ZacksPTC Therapeutics (PTCT) Reports Q2 Earnings: What Key Metrics Have to Say
ZacksPTC Therapeutics (PTCT) Reports Q2 Loss, Beats Revenue Estimates
PR NewswirePTC Therapeutics Provides Corporate Update and Reports Second Quarter 2025 Financial Results
BenzingaPTC Therapeutics Earnings Preview
ZacksPTC Therapeutics (PTCT) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
ZacksPTC Therapeutics (PTCT) Surges 11.2%: Is This an Indication of Further Gains?
BenzingaSephience Gets FDA Approval, Now A Key Revenue Driver For PTC Therapeutics
BenzingaThese Analysts Increase Their Forecasts On PTC Therapeutics
PR NewswirePTC Therapeutics Announces FDA Approval of Sephience™ (sepiapterin) for the Treatment of Children and Adults Living with Phenylketonuria (PKU)
PR NewswirePTC Therapeutics to Host Conference Call to Discuss Second Quarter 2025 Financial Results
PR NewswireSephience™ (sepiapterin) Granted Marketing Authorization by the European Commission for the Treatment of Children and Adults Living with Phenylketonuria (PKU)
PR NewswireINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PTC Therapeutics, Inc. - PTCT
PR NewswirePTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PR NewswireINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PTC Therapeutics, Inc. - PTCT
PR NewswireINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PTC Therapeutics, Inc. - PTCT
PR NewswireINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PTC Therapeutics, Inc. - PTCT
ZacksAll You Need to Know About PTC Therapeutics (PTCT) Rating Upgrade to Buy
PR NewswireINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PTC Therapeutics, Inc. - PTCT
BenzingaPTC Therapeutics To Rally Around 61%? Here Are 10 Top Analyst Forecasts For Tuesday
PR NewswireINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PTC Therapeutics, Inc. - PTCT
PR NewswireINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PTC Therapeutics, Inc. - PTCT
PR NewswireINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PTC Therapeutics, Inc. - PTCT
MotleyFoolPTC Therapeutics (PTCT) Q1 2025 Earnings Call
PR NewswirePTC Therapeutics Provides Corporate Update and Reports First Quarter 2025 Financial Results
BenzingaWhy Did PTC Therapeutics Stock Fall On Monday Despite Mid-Stage Study For Huntington's Hits Primary Goal?
PR NewswirePTC518 PIVOT-HD Study Achieves Primary Endpoint
PR NewswirePTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PR NewswirePTC Therapeutics to Participate at Upcoming Investor Conferences
ZacksPTC Therapeutics (PTCT) Earnings Expected to Grow: Should You Buy?
PR NewswirePTC Therapeutics to Host Conference Call to Discuss First Quarter 2025 Financial Results
PR NewswirePTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PR NewswirePTC Therapeutics Provides Regulatory Update on Translarna™ (ataluren) in Europe
BenzingaPTC Therapeutics Reveals New Sepiapterin Data From Phase 3 Study In Patients With Inherited Disorder, FDA Decision Expected In July
PR NewswirePTC Therapeutics Presents New Sepiapterin Data from Ongoing Studies

PTC Therapeutics News

PTC Therapeutics News: auf dieser Seite finden Sie alle PTC Therapeutics News und Nachrichten zur PTC Therapeutics Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch PTC Therapeutics News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um PTC Therapeutics News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.